Views & Analysis Bad behaviour: why understanding human behaviour can improve... Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour.
Views & Analysis Behaviour science: the new capability every pharma company s... Mark Lightowler takes a look at why medical interventions are evolving beyond drugs to also help patients change behaviours that impact their disease.
Views & Analysis How behavioural science is helping in the fight against COVI... Thanks to COVID-19, just about every form of media we consume right now is focused on aspects of changing how we live.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face